Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NATRIUM-HF: Entresto renal response in heart failure
NCT04235062Completed
- Sponsor
- Momentum Biotechnologies
- Start
- Apr 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Open-label, single-arm trial of sacubitril + valsartan in heart failure (HF), sponsored by Momentum Biotechnologies. Primary endpoints: Natriuretic response to intravascular volume expansion at 3 months and Natriuretic response to IV diuretic administration at 3 months. Started Apr 2020; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04235062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04235062.